GV-backed start­up Rani gets $53M from new in­vestors for 'ro­bot­ic pil­l'

A Google-backed start­up that’s de­vel­op­ing a new way to turn in­jectable drugs like in­sulin in­to pills, has raised an ad­di­tion­al $53 mil­lion from a slew of new in­vestors to prep for clin­i­cal tri­als.

The com­pa­ny, called Rani Ther­a­peu­tics, has now raised $142 mil­lion in to­tal fund­ing, with ex­ist­ing in­vestors in­clud­ing Al­pha­bet’s ven­ture arm GV, along with No­var­tis, As­traZeneca, and oth­ers. New in­vestors to the par­ty are Gene­Science Phar­ma­ceu­ti­cals, a ma­jor bio­phar­ma com­pa­ny in Chi­na, along with Shire, Bossa Ven­tures, and Cathay Ven­ture.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER